Author

J. Kayiwa

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Cocirculation of Human Monkeypox Virus Clade 1b with Varicella Zoster Virus, Uganda

In July 2024, we reported information on the initial human mpox cases in Uganda. Genomic characterization of clinically suspected cases (July–December 2024) revealed cocirculation of several monkeypox virus clade 1b clusters and varicella zoster virus. Our findings highlight the need to refine differential diagnoses by...

N. Bbosa, A. Ssekagiri, H. Namagembe et al. · Emerging Infectious Diseases · 0 citations

Sep 2026

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

BACKGROUND Fractional doses of yellow fever vaccines have been shown to be safe and immunogenic in randomised controlled trials in adults and children. However, little evidence still remains in children younger than 2 years. We assessed immunogenicity of one-fifth (0·1 mL) and one-half (0·25 mL) fractional doses compar...

Reena H. Doshi, Irene Lubega, Pierre Muhoza et al. · The Lancet · 0 citations

Open access Sep 2026

Types, Subtypes and Positivity Rates of Seasonal Influenza in Uganda, 2019-2023

Background: Seasonal influenza, commonly known as flu, is an acute respiratory, highly contagious illness caused by influenza viruses. A clear understanding of influenza seasonality is crucial for guiding prevention and treatment strategies, including decisions on vaccination timing to prevent outbreaks. While well doc...

M. Nankya, N. Owor, J. Kayiwa et al. · medRxiv · 0 citations